BioLineRx Announces In-licensing of Liver Fibrosis Project Under Strategic Collaboration

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. V
4. STX
5. PYPL
6. KLAC
7. SPY
8. F
9. CSGP
10. BE

Go back to BioLineRx Announces In-licensing of Liver Fibrosis Project Under Strategic Collaboration
Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.75 --0 (-0%)
Previous Close $2.75    52 Week High $1.63 
Open $2.75    52 Week Low $0.71 
Day High $2.75    P/E N/A 
Day Low $2.75    EPS $0.00 
Volume 21       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.75 --0 (-0%)
Previous Close $2.75    52 Week High $1.63 
Open $2.75    52 Week Low $0.71 
Day High $2.75    P/E N/A 
Day Low $2.75    EPS $0.00 
Volume 21